Results 51 to 60 of about 295,979 (212)

Osteoporosis in a murine model of postmenopausal lupus [PDF]

open access: yes, 2020
Background/objective Postmenopausal women with systemic lupus erythematosus have an increased risk of osteoporosis and associated fractures. Their increased osteoporosis risk is probably caused by a high level of inflammation, use of glucocorticoids ...
Lagerquist, Marie K,   +5 more
core   +1 more source

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study [PDF]

open access: yes, 2013
We determined whether any individual cancers are increased or decreased in a cohort of 595 patients with systemic lupus erythematosus (SLE) followed for up to 32 years at the University College London Hospitals Lupus Clinic, looking for any associated ...
Kenu, E, Dey, D, Isenberg, DA
core  

Belimumab : a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis [PDF]

open access: yes, 2013
Objectives: To undertake a systematic review and meta-analysis to investigate clinical effectiveness of belimumab for patients with systemic lupus erythematosus (SLE) and antinuclear and/or anti-double-stranded DNA (dsDNA) autoantibodies.
Hartley, Louise   +17 more
core   +1 more source

Are Tattoos Safe in Patients With Systemic Lupus Erythematosus? Results From a Single-Center Study

open access: yesDermatology Practical & Conceptual
Introduction: Systemic Lupus Erythematosus is a pleiotropic autoimmune disease with common skin involvement. To date, only one study has investigated tattoos safety in SLE patients.
Francesco Natalucci   +6 more
doaj   +1 more source

Feasibility and Utility of a Pilot Peer Education Program to Improve Patient Engagement in Lupus Clinical Trials: Implementation and Evaluation in a Multisite Model Within a Lupus Clinical Trials Network

open access: yesACR Open Rheumatology, 2023
Objective To assess outcomes related to Lupus Therapeutics’ Patient Advocates for Lupus Studies (LT‐PALS), a peer‐to‐peer lupus clinical trial (LCT) education program designed to improve representation of diverse groups in LCTs.
Saira Z. Sheikh   +12 more
doaj   +1 more source

THE IDENTITY OF LUPUS VULGARIS AND LUPUS ERYTHEMATODES. [PDF]

open access: yesJAMA: The Journal of the American Medical Association, 1896
In common with all other branches of medicine, dermatology has felt the result of modern bacteriologic investigations. The brilliant discoveries of Koch, the father of bacteriology, have shattered many idols and put a different aspect upon many things. The advances wrought have been so enormous as to thoroughly have revolutionized some matters.
openaire   +1 more source

ICF Core Sets: how to specify impairment and function in systemic lupus erythematosus [PDF]

open access: yes, 2006
The World Health Organization’s International Classification of Function (ICF) is a tool to characterize and illuminate better the full of array of problems a patient faces when affected by disease.
Pisetsky, D.S.   +7 more
core   +1 more source

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature [PDF]

open access: yes, 2013
Cutaneous manifestations occur frequently in systemic lupus erythematosus (SLE) and are pathognomonic in subacute-cutaneous lupus erythematosus (SCLE) and chronic cutaneous lupus erythematosus (CCLE).
Morris, SD   +3 more
core  

Genetic variants in FH are associated with renal histopathologic subtypes of lupus nephritis: a large cohort study from China [PDF]

open access: yes, 2017
Objective Genetic variants in FH (complement factor H) were reported to associate with susceptibility to systemic lupus erythematosus (SLE). This study proposed that the genetic defects of FH in the susceptibility and in the development of lupus ...
Tan, M.   +19 more
core   +1 more source

A tissue-selective estrogen complex as treatment of osteoporosis in experimental lupus [PDF]

open access: yes, 2022
Osteoporosis is a common secondary complication in patients with systemic lupus erythematosus (SLE). Current osteoporosis treatment with bisphosphonates has some negative side effects and there is a lack of data regarding newer treatments options for SLE
Gupta, Priti,   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy